Kalkine has a fully transformed New Avatar.
Core Laboratories N.V.
CLB Details
Core Laboratories N.V. (NYSE: CLB) is a major provider of patented reservoir description and production improvement and reservoir management services to the oil and gas industry. These services help CLB's clients enhance reservoir performance and recover more oil and gas from their producing fields. It employs around 3,700 people worldwide and has over 70 offices in over 50 countries.
Latest News:
9MFY21 Results:
Key Risks:
Outlook:
Valuation Methodology: Price/Earnings Per Share Based Relative Valuation
(Analysis by Kalkine Group)
CLB Daily Technical Chart (Source: REFINITIV)
Stock Recommendation:
CLB's stock price has fallen 25.35% in the past nine months and is currently leaning towards the lower band of its 52-week range of USD 14.44 to USD 49.87. The stock is currently trading below its 50 and 200 DMA levels, and its RSI Index is at 43.81. We have valued the stock using the Price/Earnings-based relative valuation methodology and arrived at a target price of USD 33.20.
Considering the correction in the stock price, market dominance, consistent dividend yield, current valuation, and associated risks, we recommend a "Speculative Buy" rating on the stock at the current price of USD 26.80, up 3.55% as of November 03, 2021, 12:31 PM ET.
* The reference data in this report has been partly sourced from REFINITIV.
* All forecasted figures and industry information have been taken from REFINITIV.
*Depending upon the risk tolerance, investors may consider unwinding their positions in a respective stock once the estimated target price is reached.
Tupperware Brands Corporation
TUP Details
Tupperware Brands Corporation (NYSE: TUP) is a company that produces and distributes culinary, home storage, and cosmetic goods. Under the Tupperware brand, the company provides food preparation, storage, serving items, cookware and microfiber fabrics. TUP sells its products in approximately 70 countries, primarily through independent distributors all around the world. In addition, its goods are offered directly to consumers through an independent sales force outside of typical retail shop locations through the direct-to-consumer channel.
Latest News:
9MFY21 Results:
Key Risks:
Valuation Methodology: Price/Earnings Per Share Based Relative Valuation
(Analysis by Kalkine Group)
TUP Daily Technical Chart (Source: REFINITIV)
Stock Recommendation:
TUP's stock price has fallen 40.77% in the past nine months and is currently leaning towards the lower band of its 52-week range of USD 18.62 to USD 38.59. The stock is currently trading below its 50 and 200 DMA levels, and its RSI Index is at 35.20. We have valued the stock using the Price/Earnings-based relative valuation methodology and arrived at a target price of USD 24.56.
Considering the sharp correction in the stock price, strategic divestitures, current valuation, and associated risks, we recommend a "Speculative Buy" rating on the stock at the current price of USD 19.93, down 15.05% as of November 03, 2021, 9:43 AM ET.
* The reference data in this report has been partly sourced from REFINITIV.
* All forecasted figures and industry information have been taken from REFINITIV.
*Depending upon the risk tolerance, investors may consider unwinding their positions in a respective stock once the estimated target price is reached.
Disclaimer - This report has been issued by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and prepared by Kalkine and its related bodies corporate authorised to provide general financial product advice. Kalkine.com.au and associated pages are published by Kalkine.
Any advice provided in this report is general advice only and does not take into account your objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your objectives, financial situation and needs before acting upon it.
There may be a Product Disclosure Statement, Information Statement or other offer document for the securities or other financial products referred to in Kalkine reports. You should obtain a copy of the relevant Product Disclosure Statement, Information Statement or offer document and consider the statement or document before making any decision about whether to acquire the security or product.
You should also seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice in this report or on the Kalkine website. Not all investments are appropriate for all people.
The information in this report and on the Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of information contained in its reports, newsletters and websites. All information represents our views at the date of publication and may change without notice.
Kalkine does not guarantee the performance of, or returns on, any investment. To the extent permitted by law, Kalkine excludes all liability for any loss or damage arising from the use of this report, the Kalkine website and any information published on the Kalkine website (including any indirect or consequential loss, any data loss or data corruption). If the law prohibits this exclusion, Kalkine hereby limits its liability, to the extent permitted by law, to the resupply of services.
Please also read our Terms & Conditions and Financial Services Guide for further information.
On the date of publishing this report (referred to on the Kalkine website), employees and/or associates of Kalkine and its related entities do not hold interests in any of the securities or other financial products covered on the Kalkine website.
Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.